InflaRx NV (IFRX)
1.56
+0.03
(+1.96%)
USD |
NASDAQ |
Oct 23, 16:00
1.57
+0.01
(+0.64%)
After-Hours: 20:00
InflaRx Market Cap : 229.89M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 229.89M |
| October 22, 2026 | 225.47M |
| October 21, 2026 | 228.42M |
| October 20, 2026 | 226.95M |
| October 19, 2026 | 213.68M |
| October 16, 2026 | 194.53M |
| October 15, 2026 | 212.21M |
| October 14, 2026 | 218.10M |
| October 13, 2026 | 228.42M |
| October 12, 2026 | 234.32M |
| October 09, 2026 | 235.79M |
| October 08, 2026 | 225.47M |
| October 07, 2026 | 229.89M |
| October 06, 2026 | 232.84M |
| October 05, 2026 | 247.58M |
| October 02, 2026 | 253.47M |
| October 01, 2026 | 252.00M |
| September 30, 2026 | 265.26M |
| September 29, 2026 | 272.63M |
| September 28, 2026 | 268.21M |
| September 25, 2026 | 278.53M |
| September 24, 2026 | 284.42M |
| September 23, 2026 | 288.84M |
| September 22, 2026 | 306.53M |
| September 21, 2026 | 312.42M |
| Date | Value |
|---|---|
| September 18, 2026 | 308.00M |
| September 17, 2026 | 303.58M |
| September 16, 2026 | 300.63M |
| September 15, 2026 | 297.68M |
| September 14, 2026 | 312.42M |
| September 11, 2026 | 308.00M |
| September 10, 2026 | 302.10M |
| September 09, 2026 | 308.00M |
| September 08, 2026 | 319.79M |
| September 04, 2026 | 327.16M |
| September 03, 2026 | 328.63M |
| September 02, 2026 | 337.47M |
| September 01, 2026 | 318.32M |
| August 31, 2026 | 313.89M |
| August 28, 2026 | 328.63M |
| August 27, 2026 | 334.53M |
| August 26, 2026 | 356.63M |
| August 25, 2026 | 362.53M |
| August 24, 2026 | 302.10M |
| August 21, 2026 | 309.47M |
| August 20, 2026 | 297.68M |
| August 19, 2026 | 312.42M |
| August 18, 2026 | 321.26M |
| August 17, 2026 | 305.05M |
| August 14, 2026 | 300.63M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| MediGene AG | 1.474M |
| BioNTech SE | 22.13B |
| Immatics NV | 999.20M |
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
Market Cap Related Metrics
| PS Ratio | 1750.70 |
| Price to Book Value | 1.376 |
| Price | 1.56 |
| Earnings Yield | -41.56% |